Case Report: Tocilizumab for Acute Kidney Graft Dysfunction in Patient Affected by COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was isolated in January 2020 and, on March, the WHO declared the status of a pandemic. It causes a cytokine release syndrome, called “cytokine storm,” characterized by systemic inflammation involving elevated levels of cytokines and hypera...
Saved in:
Main Authors: | Infante Barbara, Mercuri Silvia, Troise Dario, Castellano Giuseppe, Giovanni Stallone |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b057a0dfb3ee449f8acb1c627e17313a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Incidence of Mortality, Acute Kidney Injury and Graft Loss in Adult Kidney Transplant Recipients with Coronavirus Disease 2019: Systematic Review and Meta-Analysis
by: Jia-Jin Chen, et al.
Published: (2021) -
Etiological and Clinical Evaluations of Patients with Acute Allograft Dysfunction Within the First Year Address
by: Eren Soyaltın, et al.
Published: (2021) -
Tocilizumab-Induced Sweet Syndrome in a Patient With Polymyalgia Rheumatica
by: Federica Filippi, et al.
Published: (2019) -
Artificial Intelligence—A Tool for Risk Assessment of Delayed-Graft Function in Kidney Transplant
by: Andrzej Konieczny, et al.
Published: (2021) -
Cholemic Nephropathy as Cause of Acute and Chronic Kidney Disease. Update on an Under-Diagnosed Disease
by: Francesca Tinti, et al.
Published: (2021)